CIK 0001788028 · <br>Emerging growth company
Jasper Therapeutics, Inc.
Sign in to watch- Ticker
- JSPR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842984849
- Phone
- 6505491400
- Business address
- 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
- Former names
- Amplitude Healthcare Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-07 | Klein Lawrence Otto Director | Grant or award · Stock Option (right to buy) | +47,000 | 47,000 | ||
| 2023-06-07 | EMSTER KURT VON Director | Grant or award · Stock Option (right to buy) | +47,000 | 47,000 | ||
| 2023-06-07 | Shizuru Judith Anne Director | Grant or award · Stock Option (right to buy) | +47,000 | 47,000 | ||
| 2023-06-07 | Nolet Chris Director | Grant or award · Stock Option (right to buy) | +47,000 | 47,000 | ||
| 2023-06-07 | Lis William Director | Grant or award · Stock Option (right to buy) | +47,000 | 47,000 | ||
| 2023-06-07 | French Anna Louise Director | Grant or award · Stock Option (right to buy) | +47,000 | 47,000 | ||
| 2023-04-14 | French Anna Louise Director | Sale | −7,000 | $1.48 | $10K | 23,750 |
| 2023-04-13 | EMSTER KURT VON Director | Sale | −9,075 | $1.49 | $14K | 21,175 |
| 2023-04-13 | Lis William Director | Sale | −8,500 | $1.44 | $12K | 61,486 |
| 2023-04-12 | MARTELL RON President, CEO and Director | Shares withheld for taxes | −87,531 | $1.46 | $128K | 418,719 |
| 2023-04-12 | Mahal Jeetinder Singh See Remarks | Shares withheld for taxes | −37,126 | $1.46 | $54K | 287,223 |
| 2023-03-17 | Mahal Jeetinder Singh See Remarks | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2023-03-17 | MARTELL RON President, CEO and Director | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2023-02-16 | Kapoor Vishal Director | Grant or award · Stock Option (right to buy) | +109,383 | 109,383 | ||
| 2023-02-02 | MARTELL RON President, CEO & Director | Grant or award · Stock Option (right to buy) | +1,093,831 | 1,093,831 | ||
| 2023-01-27 | Qiming U.S. Healthcare Fund II, L.P. 10% owner | Purchase | +2,666,666 | $1.50 | $4.0M | 8,519,648 |
| 2023-01-27 | Carlyle Group Inc. 10% owner | Purchase | +3,133,333 | $1.50 | $4.7M | 8,761,891 |
| 2023-01-25 | ROCHE HOLDING LTD 10% owner | Sale | −75,000 | $1.89 | $142K | 4,549,606 |
| 2022-10-12 | MARTELL RON President, CEO and Director | Grant or award | +506,250 | 506,250 | ||
| 2022-10-12 | Klein Lawrence Otto Director | Grant or award | +24,500 | 24,500 |
Page 5 of 7 · 129 trades